Microdoses of psychedelic Mushrooms may improve mood and mental health
Evidence from studies suggests that microdosing psychedelic mushrooms can improve cognitive function and alleviate symptoms of depression and anxiety.
Microdosing refers to the practice of regularly using small amounts of psychedelic substances that do not impair cognitive function.
A study now shows that individuals who microdose psilocybin showed improved mood and a greater decline in anxiety, depression, and stress over a one-month period than those who did not microdose.
Notably, these improvements in mental health and mood associated with microdosing psilocybin were also observed in individuals with mental health concerns.
A large study recently published in the journal Scientific Reports Trusted Sources hows that microdosing trusted source psilocybin trusted Source resulted in greater improvements in mental health and mood than in individuals who did not engage in microdosing.
The study’s co-author Joseph Rootman, a doctoral student at the University of British Columbia, said that the study was “the largest longitudinal study to date” on microdosing psilocybin and one of the few pieces of research to include a control group.
“We found psilocybin microdosing to be associated with improvements in mood and mental health, which adds to the growing body of research that suggests positive benefits of microdosing specifically in the domains of mental health and cognition.” said.